Software biz scores one for mammography by algorithm

Dave Pearson | | Health Imaging | Womens Imaging

A healthcare-software startup in Israel is reporting that it has created a constantly improving algorithm that is better at reading mammography exams “than radiologists using the best computer-aided detection methods.”

The company’s CMO tells Business Insider the algorithm can find half of the breast cancer cases that are currently being missed by radiologists.

Get the rest:  

An Israeli startup says it has taught an algorithm how to detect breast cancer

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

How radiologists can help identify victims of domestic violence
New low-field scanner detects cancer spread better than traditional breast MRI
New FDA-cleared algorithm could improve fetal anomaly detection on ultrasound
MRI technique makes breast cancer 'glow' on imaging
Commercially insured women less likely to be referred for interventional procedures
Deep learning reconstruction cuts breast MRI scan times in half

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.